latest news in Pharmaceutical Tariffs
Bristol Myers Squibb Secures Tariff Exemption via Medicaid Access Deal
Princeton, Saturday, 20 December 2025.
In a strategic trade-off with the Trump administration, Bristol Myers Squibb secures a three-year tariff exemption by providing Eliquis free to Medicaid and donating seven tons of active pharmaceutical ingredients.